UBS Downgrades Charles River Labs (CRL) to Sell
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
UBS downgraded Charles River Labs (NYSE: CRL) from Neutral to Sell with a price target of $78.00 (from $83.00).
Shares of Charles River Labs closed at $84.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Time Warner (TWX) to Neutral Following Takeover
- Susquehanna Cuts Price Target on KLA-Tencor (KLAC) Following Strong 1Q
- Jefferies Reiterates Buy on PPG Industries (PPG) - PT to $113
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades, Hot Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!